Navigation Links
Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
Date:11/6/2008

SAN CARLOS, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it has repurchased 32%, or $100.0 million, of its outstanding convertible debt for approximately 48 cents on the dollar, for a total purchase price of $47.8 million. The company also reported its financial results for the third quarter and nine-months ended September 30, 2008.

"The turnaround at Nektar is now largely complete," said Nektar President and CEO Howard W. Robin. "We have created one of the most robust pipelines in biotech, dramatically improved the company's financial strength, assembled a new management team with a solid track record, and refocused the business around our powerful polymer and conjugate chemistry drug development platform."

Third Quarter 2008 Financial Results

Cash, cash equivalents, and short-term investments were $344.5 million at September 30, 2008 compared to $373.9 million at June 30, 2008.

Revenue for the three month period ended September 30, 2008 was $21.4 million compared to revenue of $56.3 million in the third quarter of 2007. For the first nine months of 2008, revenue was $61.8 million as compared to $207.3 million in the same period of 2007. This decrease in revenue is primarily the result of lower product manufacturing revenues due to the termination of the inhaled insulin collaboration by Pfizer in late 2007.

Nektar has continued to make significant improvements to its operating efficiencies as compared to a year ago. For the first nine months of 2008, the company's general and administrative expense was $37.0 million as compared to $42.3 million for the same period a year ago. Research and development expense was $109.1 million in the first nine months
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. Nektar Therapeutics Announces First Quarter 2008 Results
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
7. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
10. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
11. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business ... which is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the ... Proceedings of the National academy of Sciences, and has given researchers inklings to explore ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... anticipating testing regulations imposed by the FDA for nicotine laced liquid products. Their ... electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a nationally ... Kalamazoo Strength & Conditioning. , The name change coincides with the release of ... training center over the past three years,” according to Jack Kelly, the center’s ...
(Date:7/29/2015)... ... 2015 , ... San Fernando Valley skin doctor , Dr. Peyman Ghasri, ... patients can get the complete treatment process with a 10 percent discount on the ... and have loose or sagging skin. , As the only non-surgical procedure approved ...
(Date:7/29/2015)... ... 29, 2015 , ... For the second year in a row, the management ... the 50 fastest growing companies in Jacksonville. This annual list is compiled by the ... a team of Vast Bridges staffers were on hand to receive the award naming ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Vast Bridges Continues Its Swift Growth 2
... cause permanent damage, researchers say , , FRIDAY, Feb. 8 ... and cause problems such as disturbed sleep, depression, anxiety ... , Researchers at Northwestern University,s Feinberg School of Medicine ... in people with chronic low back pain while they ...
... during the transition from high school through the first ... psychological implications, according to a report out of the ... good news is that during the first year of ... majority (78 percent) of the 870 incoming freshmen women ...
... NHS Choices ( http://www.nhs.uk ), the,online ,front ... news service to,help people make sense of the ... Behind the headlines, on NHS Choices,( http://www.nhs.uk/News/Pages/NewsIndex.aspx ), ... the news. The service explains the,facts behind newspaper ...
... - code situations in hospital parlance - easily expose common ... for children and also set up powerful incentives to ... a study from the Johns Hopkins Childrens Center. , ... and published in the January issue of Pediatrics, found sometimes ...
... 8 Symmetry Medical Inc.,(NYSE: SMA ), a ... industry and other medical markets, today announced it,will provide ... on,February 14, 2008 before the opening of the U.S. ... at 8:00 a.m. ET on,February 14, 2008., A ...
... Annual Event Raises Funds and Awareness for Chronic ... Feb. 8 The following release was,issued today ... Capital,Area:, WHO: Casino Night attracts a diverse ... medical and philanthropic communities in the Greater,Washington, DC ...
Cached Medicine News:Health News:Chronic Pain Harms Brain's Wiring 2Health News:A dangerous transition: High school to the first year of college 2Health News:A dangerous transition: High school to the first year of college 3Health News:A dangerous transition: High school to the first year of college 4Health News:Mock CPR 'codes' expose weaknesses in hospital emergency response for children 2Health News:Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008 2
(Date:7/29/2015)... , July 29, 2015 Alvarado ... 23, called the Alvarado Spine & Joint Institute. ... and rehabilitation, focusing on spinal surgery and joint ... patient care takes a patient experience-focused approach. For ... they feel comfortable in, rather than patient gowns. ...
(Date:7/29/2015)... --  Turing Pharmaceuticals AG announced today that ... its first Chief Communication Officer. In this ... internal and external communications and will provide counsel to ... to Founder and Chairman, Martin Shkreli , and ... "We are excited to have Craig join Turing and ...
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3Global Neurostimulation Devices Market 2015-2019 2
... 2007 /PRNewswire/ -- Alfacell,Corporation today announced that ... officer and corporate secretary, will,present an overview ... a.m. EDT on Thursday, July 12, 2007, ... Conference in New York. , The audio ...
... and NORTH BRUNSWICK, New Jersey, July 03, 2007,/PRNewswire-FirstCall/ ... announced today that J. Michael French, Rosetta Genomics,President, ... Conference on Tuesday, July 10, at 11:00 am ... , A live audio webcast of the presentation ...
Cached Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
... fingertip ratchet disengagement allowing smooth, ratchet-free grasping. ... state-of-the-art quality in an instrument of extremely ... Low profile cutting tips allow access to ... instruments are available in just about every ...
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
... A broad selection of procedurally ... capability and allow easy access to ... a variety of approaches.,Loop Handled Graspers ... that holds tissue firmly without tearing ...
Medicine Products: